1. Home
  2. NKTR vs UPBD Comparison

NKTR vs UPBD Comparison

Compare NKTR & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$37.08

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$17.01

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
UPBD
Founded
1990
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NKTR
UPBD
Price
$37.08
$17.01
Analyst Decision
Buy
Buy
Analyst Count
15
6
Target Price
★ $133.08
$27.50
AVG Volume (30 Days)
★ 1.4M
1.0M
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
★ 8.98%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.98
Revenue
$307,711,000.00
★ $4,695,061,000.00
Revenue This Year
N/A
$0.81
Revenue Next Year
$30.00
$4.07
P/E Ratio
★ N/A
$17.74
Revenue Growth
★ 86.00
8.67
52 Week Low
$33.40
$14.98
52 Week High
$109.00
$23.98

Technical Indicators

Market Signals
Indicator
NKTR
UPBD
Relative Strength Index (RSI) 29.12 56.50
Support Level $34.45 $17.00
Resistance Level $39.59 $19.50
Average True Range (ATR) 1.98 0.57
MACD 0.66 0.28
Stochastic Oscillator 22.11 83.98

Price Performance

Historical Comparison
NKTR
UPBD

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: